New heart valve device offers hope for high-risk patients
NCT ID NCT07172477
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 19 times
Summary
This study tests a new device called Pivot Extend for people with severe tricuspid regurgitation, a leaky heart valve. The device is placed using a thin tube through a blood vessel, avoiding open-heart surgery. The study includes 10 adults who are at high risk for surgery. The goal is to see if the device is safe and can improve symptoms like shortness of breath and fatigue.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRICUSPID REGURGITATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Macquarie University
RECRUITINGMacquarie Park, New South Wales, 2109, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.